SynergyとPureはElevance Healthの株式を増やし、予想をわずかに下回る収益と14.3%の収益成長を報告しました。 Synergy and Pure increased stakes in Elevance Health, which reported slightly below-expected earnings and 14.3% revenue growth.

Synergy Asset ManagementとPure Financial Advisorsは、第2四半期にElevance Healthへの出資を増やし、同社は予想をわずかに下回る8.84ドルの1株当たり利益と、前年同期比14.3%増の494億2,000万ドルの収益を報告しました。 Synergy Asset Management and Pure Financial Advisors increased their stakes in Elevance Health during the second quarter, with the company reporting $8.84 in earnings per share, slightly below estimates, and $49.42 billion in revenue, up 14.3% year-over-year. CEOのゲイル・ブードローとスザン・D・デヴォアは 最近の株式購入を通じて 所有権を強化した CEO Gail Boudreaux and Director Susan D. Devore boosted their ownership through recent share purchases. 株式の市場資本は76.6億円,P/e比は14.48ドル,"モデレート・バイヤー"は411.06ドルで評価される. The stock has a market cap of $76.6 billion, a P/E ratio of 14.48, and a “Moderate Buy” consensus rating with a $411.06 price target.